FIBROMYXOID TUMOR

Clinical trials for FIBROMYXOID TUMOR explained in plain language.

Never miss a new study

Get alerted when new FIBROMYXOID TUMOR trials appear

Sign up with your email to follow new studies for FIBROMYXOID TUMOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

Immunotherapy duo takes on rare tumors in major trial

Disease control Ongoing

This study tests whether combining two immunotherapy drugs, nivolumab and ipilimumab, can shrink tumors in people with rare cancers. About 800 participants with over 50 different rare tumor types received these drugs to boost their immune system's ability to fight cancer. The goa…

Matched conditions: FIBROMYXOID TUMOR

Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Jun 15, 2026 19:03 UTC

FIBROMYXOID TUMOR

Get alerted when new FIBROMYXOID TUMOR trials appear

Immunotherapy duo takes on rare tumors in major trial